department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Doxepin Hydrochloride · pharmadog

pharmadog
drugs
Doxepin Hydrochloride

drug

patient view →

doxepin hydrochloride

Marketedupdated 2mo ago

by RK Pharma Inc

Approved

community read0 votes

indications

investigational

Major Depression

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Doxepin Hydrochloride

generic

doxepin hydrochloride

indication

Anxiety Disorders

phase

marketed

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Patent cliff

source: FDA Orange Book

first barrier falls

May 18, 2027

315 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (32)

Sep 7, 2030method-of-use (U-620)US 85132994.2y
Sep 7, 2030method-of-use (U-620)US 85132994.2y
Jun 1, 2029formulationUS 95329712.9y
Jun 1, 2029formulationUS 95329712.9y
May 1, 2028method-of-use (U-620)US 91078981.8y
May 1, 2028method-of-use (U-620)US 91078981.8y
Apr 11, 2028method-of-use (U-620)US 105488711.8y
Apr 11, 2028method-of-use (U-620)US 105488711.8y
Apr 11, 2028method-of-use (U-620)US 110969201.8y
Apr 11, 2028method-of-use (U-620)US 110969201.8y
Apr 11, 2028formulationUS 99077801.8y
Apr 11, 2028formulationUS 99077801.8y
Jan 18, 2028method-of-use (U-620)US 112349541.5y
Jan 18, 2028method-of-use (U-620)US 112349541.5y
Aug 24, 2027method-of-use (U-620)US 79153071.1y
Aug 24, 2027method-of-use (U-620)US 79153071.1y
Jul 20, 2027method-of-use (U-620)US 106536601.0y
Jul 20, 2027method-of-use (U-620)US 106536601.0y
Jul 20, 2027method-of-use (U-620)US 111100741.0y
Jul 20, 2027method-of-use (U-620)US 111100741.0y
Jul 20, 2027method-of-use (U-620)US 95728141.0y
Jul 20, 2027method-of-use (U-620)US 95728141.0y
May 18, 2027method-of-use (U-620)US 10238620315d
May 18, 2027method-of-use (U-620)US 10238620315d
May 18, 2027method-of-use (U-620)US 10653662315d
May 18, 2027method-of-use (U-620)US 10653662315d
May 18, 2027method-of-use (U-620)US 12083090315d
May 18, 2027method-of-use (U-620)US 12083090315d
May 18, 2027method-of-use (U-620)US 9486437315d
May 18, 2027method-of-use (U-620)US 9486437315d
May 18, 2027method-of-use (U-620)US 9861607315d
May 18, 2027method-of-use (U-620)US 9861607315d

🐶 often sniffed alongside

top 3

companyAlembic Pharmaceuticals Inc3 co-mentions · 1 sources
drugZonalon1 co-mentions · 1 sources
tagRecall1 co-mentions · 1 sources

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?